Seeking Alpha

cgarrett101

cgarrett101
Send Message
View cgarrett101's Comments BY TICKER:
  • Is The Hep C Drug Pipeline Beginning To Crack? [View article]
    "11:48 AM Deutsche Bank defends Gilead (GILD -1.6%) in the wake of the FDA's halting of Phase II clinical trials for Idenix's drug IDX184 over safety concerns, saying it's a buying opportunity. The firm says the concern is with non-quanosine nukes, and notes Gilead's GS 7977 is a pyrimidine based nuke. It reiterates its Buy rating with a $68 price target. "
    Aug 16, 2012. 01:30 PM | Likes Like |Link to Comment
More on IDIX by cgarrett101
COMMENTS STATS
19 Comments
8 Likes